Replies to post #8434 on Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

What I’m saying is no analysts have modeled VOS into their share price yet. It is way too early and they are going against a placebo in the ph2/3 trial so it will be a long trial. You realize they just finished just a conceptual trial for VOS right? I’ll repeat, LN will determine the future of Aurina.